Showing 1731-1740 of 1960 results for "".
- Restylane Kysse Shows Positive Kissability Satisfaction in Phase 4 Studyhttps://modernaesthetics.com/news/restylane-kysse-shows-positive-kissability-satisfaction-in-phase-4-study/2472966/In a first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, researchers evaluated subject satisfaction as well as partner satisfaction following treatment with Restylane Kysse. Many consumers report they often keep their lip treatments a
- Allergan Donates $300K to Bridge the Gender Gap in STEMhttps://modernaesthetics.com/news/allergan-donates-300k-to-bridge-the-gender-gap-in-stem/2472964/Allergan has pledged $300K to support STEM Education through their partnership with Girls Inc. In addition to the donation, Allergan is also offering mentoring initiatives and resources to educate and empower future female leaders interest
- Endo’s Qwo Scores FDA Nod for Cellulite Treatmenthttps://modernaesthetics.com/news/endos-qwo-scores-fda-nod-for-cellulite-treatment/2472961/The FDA has given its nod to an entirely new way to address cellulite. Endo Aesthetic’s Qwo (collagenase clostridium histolyticum-aaes) is the first injectable treatment for moderate to severe cellulite of the buttocks in adult women. When fat in cellulite-prone areas swells and e
- Survey: Facial Plastic Surgeons Should Get Ready for the Zoom Boomhttps://modernaesthetics.com/news/survey-facial-plastic-surgeons-should-get-ready-for-the-zoom-boom/2472960/All of that Zoom has led to a boom in requests for facial plastic surgery, according to research published in The Journal of Facial Plastic Surgery and Aesthetic Medicine. The months spent on Zoom and other video conferencing services during the COVID-19 quarantine got a lot of
- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc
- FDA Approves Juvéderm Voluma XC for Augmentation for Chin Regionhttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-augmentation-for-chin-region/2472953/The FDA has approved Allergan Aesthetics' Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. According to Allergan Aesthetics, an AbbVie company, the Juvéderm Collection of Fillers has the broadest portfolio of sp
- Alastin Skincare's INhance Post-Injection Serum Speeds Recoveryhttps://modernaesthetics.com/news/alastin-skincares-inhance-post-injection-serum-speeds-recovery/2472951/Alastin’s Skincare’s INhance Post-Injection Serum with TriHex Technology can help reduce post-injection bruising and swelling, according to a report inthe Journal of Drugs in
- Obagi Rolls Out Two New Sunscreens and a Serumhttps://modernaesthetics.com/news/obagi-drops-two-new-sunscreens-and-a-serum-1/2472950/Obagi is launching two new Physical Defense Sunscreens and Daily Hydro-Drops. The new SUZANOBAGIMD Physical Defense Sunscreens, available in broad-spectrum SPF 40 and tinted SPF 50, defend against five light sources, including high energy visible light, or blue light, visible light
- ISHRS Survey: Brad Pitt, Eva Longoria Top List of Most-Desired Celebrity Lockshttps://modernaesthetics.com/news/brad-pitt-eva-longoria-top-list-of-most-desired-best-celebrity-locks/2472949/When it comes to celebrity hair, it’s Brad Pitt and Eva Longoria’s locks that are most admired, according to a
- ASPS: Many Americans Look Forward to Plastic Surgery in Post COVID-19 Worldhttps://modernaesthetics.com/news/asps-many-americans-look-forward-to-plastic-surgery-in-post-covid-19-world/2472948/Americans report a positive attitude about plastic surgery even during the COVID-19 pandemic, according to a new survey from the American Society of Plastic Surgery. In the survey of more than 1,000 consumers who were polled during the pandemic, 49 percent of those who haven't had p